GAMMA Investing’s Tectonic Therapeutic TECX Stock Holding History

GAMMA Investing’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.97K	Sell	290 -40	-12%	-$1.18K	﹤0.01%	3204
2026 Q1	$10.2K	Buy	330 +301	+1,038%	+$7.41K	﹤0.01%	3060
2025 Q4	$605	Buy	29 +21	+263%	+$390	﹤0.01%	3888
2025 Q3	$126	Buy	+8	New	+$165	﹤0.01%	3822
2025 Q2	–	Sell	-8	Closed	-$142	–	3906
2025 Q1	$142	Buy	+8	New	+$261	﹤0.01%	3773

Other funds holding TECX

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

GAMMA Investing's TECX Position: Q2 2026 in Review

GAMMA Investing reduced its Tectonic Therapeutic (TECX) stake by 12% in Q2 2026, selling an estimated $1.18K and leaving 290 shares worth $9.97K. The position accounts for ﹤0.01% of the portfolio, ranked #3204.

GAMMA Investing first reported a position in TECX in Q1 2025 and has held it in 5 quarters since. The position peaked at $10.2K in Q1 2026. 3 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

GAMMA Investing held 290 shares of Tectonic Therapeutic worth $9.97K as of Q2 2026.
GAMMA Investing sold 40 Tectonic Therapeutic shares in Q2 2026, an estimated $1.18K.
Tectonic Therapeutic made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3204 holding.
GAMMA Investing first reported a position in Tectonic Therapeutic in Q1 2025 and has held it in 5 quarters since.
GAMMA Investing's Tectonic Therapeutic position peaked at $10.2K in Q1 2026.
3 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.